Hundreds of critically-ill coronavirus patients will be given an arthritis drug in RECOVERY trial
Tocilizumab, marketed as Actemra, will be given to hundreds of critically ill coronavirus patients in the NHS Hundreds of critically ill coronavirus patients in the NHS will be given an arthritis drug as part of the world’s largest trial of promising therapies. Tocilizumab, sold as RoActemra or Actemra, will be administered to patients whose lungs … Read more